Pertuzumab Injection Clinical Trials

4 actively recruiting trials across 1 location

Also known as: Perjeta

Pipeline

Phase 2: 2Phase 3: 1Phase 1/2: 1

Top Sponsors

University of Chicago1
RemeGen Co., Ltd.1
Jiangsu HengRui Medicine Co., Ltd.1
DualityBio Inc.1

Indications

Breast Cancer4
Cancer4
Liver Disease1
HER2-positive Advanced Solid Tumor1
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast1

Other3 trials

A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer

Phase 3

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Phase 2

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

Phase 2

Cerritos, California1 trial

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Helios Clinical Research

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.